Integrating genetic markers, such as those weve identified in the GLP1R and GIPR genes, with clinical factors provides a clearer picture of how a patients unique biology may interact with a specific therapy, allowing both patients and their doctors to proactively manage expectations and tailor care with greater precision from day one. A Sincere Thank You to Our Participants The GLP-1 Study is ongoing, and our survey is designed to allow participants to share their journey over time so we can continue to investigate how these medications are associated with genetics and health
Ipamorelin has no FDA approval
Older people usually produce less stomach acid and therefore less intrinsic factor, increasing their risk for deficiency
Other: Hossain, A., Yamaguchi, F., Matsuo, T., Tsukamoto, I., Toyoda, Y., Ogawa, M., Nagata, Y., & Tokuda, M